Drug Allergy Clinical Trial
Official title:
Improved Basophil Activation Test (BAT) in the Diagnostics of IgE-mediated Drug Allergy
Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).
Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs). Among commonly used CD63/CD203c markers, newly proposed molecules, such as CD69, CD107a, CD164, CD13, CD11b and CD300a will be assayed. Results obtained together with the other clinical data will be used to calculate sensitivity and specificity of the method. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT06414694 -
Inpatient Penicillin Delabeling for Low-Risk Patients
|
Phase 4 | |
| Completed |
NCT05706246 -
Perioperative Hypersensitivity in Children
|
N/A | |
| Recruiting |
NCT04920721 -
Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
|
||
| Completed |
NCT02118987 -
Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
|
Phase 1 | |
| Completed |
NCT02094638 -
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
|
N/A | |
| Not yet recruiting |
NCT06399601 -
A Training Program of Drug Allergy for Healthcare Professionals
|
N/A | |
| Completed |
NCT03784482 -
Multiple Drug Hypersensitivity Syndrome
|
||
| Not yet recruiting |
NCT06406114 -
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
|
Phase 2 | |
| Recruiting |
NCT05820802 -
High Dimensional Analysis of Immune Cells in Pediatric Patients
|